Literature DB >> 8558500

(2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-2-morpholinol: a novel antidepressant agent and selective inhibitor of norepinephrine uptake.

J L Kelley1, D L Musso, G E Boswell, F E Soroko, B R Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8558500     DOI： 10.1021/jm950630p

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  3 in total

1.  Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.

Authors:  Ronald J Lukas; Ana Z Muresan; M Imad Damaj; Bruce E Blough; Xiaodong Huang; Hernán A Navarro; S Wayne Mascarella; J Brek Eaton; Syndia K Marxer-Miller; F Ivy Carroll
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

2.  Heterocycles via intramolecular platinum-catalyzed propargylic substitution.

Authors:  Qiren Liang; Jef K De Brabander
Journal:  Tetrahedron       Date:  2011-07-08       Impact factor: 2.457

3.  Transdermal delivery of bupropion and its active metabolite, hydroxybupropion: a prodrug strategy as an alternative approach.

Authors:  Paul K Kiptoo; Kalpana S Paudel; Dana C Hammell; Raghotham Reddy Pinninti; Jianhong Chen; Peter A Crooks; Audra L Stinchcomb
Journal:  J Pharm Sci       Date:  2009-02       Impact factor: 3.534
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.